Download PDF
1 / Pages

Other users also viewed these articles

Causes of hyperprolactinaemia in the primary care setting: How to optimise hyperprolactinaemia management Ana M. García Cano; Lucía Jiménez Mendiguchía; Marta Rosillo Coronado; Ana Gómez Lozano; Ángel Luis del Rey-Mejías; María Fresco Merino; Marta Marchán Pinedo; Marta Araujo-Castro;
Endocrinol Diabetes Nutr. 2022;69:771-8
Thyroid disorders associated with immune control point inhibitors Enzamaria Fidilio; Elena Navarro-González; Ana R. Romero-Lluch; Pedro Iglesias; Juan José Diez Gómez; Emma Anda Apiñániz; Estefanía Santos Mazo; Carles Zafón;
Endocrinol Diabetes Nutr. 2021;68:408-15
Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: A pilot study Robert Krysiak; Karolina Kowalcze; Bogus¿aw Okopie¿;
Endocrinol Diabetes Nutr. 2022;69:279-88